Issues Involving Controlled Substances and Pain and Addiction Drugs Generally S. 1679 Kennedy Health Care Reform Bill 
Senate Finance Committee Health Care Reform Bill
H.R. 3200 Tri-Committee Health Care Reform Bill
S. 1213, H.R. 2502 Comparative Effectiveness Research S. 1142 - Informed Health Care Decision Making Act
H.R. 3276 - Nuclear Medicine and Research Legislation
Medical Device Safety Act of 2009
Medical Device Tax
Bariatric Surgery
H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 4872 - Health Care and Education Reconciliation Act of 2010
H.R. 1191/S.1336 - Safe Drug Disposal Act of 2009
H.R. 4956 - Stop Oxy Abuse Act of 2010 H.R. 1 American Recovery and Reinvestment Act of 2009
S. Con. Res. 13
H. Con. Res. 85
H.R. 1105 Omnibus Appropriations Act, 2009 H.R. 2346, S. 1054  Supplemental Appropriations Bill, H1N1 Pandemic H.R. 23
Budget Requirements 2010
Financial Services Appropriations Bill H.R. 1260 Patent Reform Act of 2009
S. 515 Patent Reform Act of 2009 S. 301 Physician Payments Sunshine Act of 2009
S. 1213, H.R. 2502 Comparative Effectiveness Research International tax on foreign direct investment.
H..R. 1265, Stop Tax Haven Abuse Act
S. 506, Stop Tax Haven Abuse Act
PHA - Pharmacy HCR - Health Issues BUD - Budget/Appropriations CPT - Copyright/Patent/Trademark MMM - Medicare/Medicaid TAX - Taxation/Internal Revenue Code
136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 21 - Office of Science & Technology Policy (OSTP) 1 - SENATE 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 21 - Office of Science & Technology Policy (OSTP) 1 - SENATE 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 21 - Office of Science & Technology Policy (OSTP) 1 - SENATE 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 21 - Office of Science & Technology Policy (OSTP) 1 - SENATE 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 21 - Office of Science & Technology Policy (OSTP) 1 - SENATE 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 21 - Office of Science & Technology Policy (OSTP) 1 - SENATE 12 - White House Office
PODESTA GROUP, INC.
1001 G Street, NW, Suite 1000 West, Washington, DC, 20001, US
SHARON COHEN THOMAS B SPARKMAN DANIELE BAIERLEIN ANTHONY PODESTA ARANTHAN JONES STEPHEN NORTHRUP (Health Policy Director, Sen. Michael Enzi) SHARON COHEN THOMAS B SPARKMAN ARANTHAN JONES DANIELE BAIERLEIN ANTHONY PODESTA STEPHEN NORTHRUP (Health Policy Director, Sen. Michael Enzi) THOMAS B SPARKMAN ANTHONY PODESTA DANIELE BAIERLEIN DALE OAK SHARON COHEN THOMAS B SPARKMAN SHARON COHEN THOMAS B SPARKMAN ANTHONY PODESTA DANIELE BAIERLEIN STEPHEN NORTHRUP (Health Policy Director, Sen. Michael Enzi) DANIELE BAIERLEIN ANTHONY PODESTA
Health Policy Director, Sen. Michael Enzi Health Policy Director, Sen. Michael Enzi Health Policy Director, Sen. Michael Enzi